Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,691 | 52,753 | 73,995 | 125,806 | 68,963 |
| Marketable Securities | 122,724 | 111,130 | 114,564 | 60,729 | 44,825 |
| Receivables | N/A | N/A | N/A | N/A | 69 |
| TOTAL | $155,124 | $166,611 | $192,046 | $191,099 | $119,576 |
| Non-Current Assets | |||||
| PPE Net | 845 | 993 | 1,024 | 1,178 | 1,341 |
| Investments And Advances | 0 | 6,874 | 4,885 | 8,067 | 0 |
| Other Non-Current Assets | 3,278 | 3,246 | 2,687 | 1,974 | 1,985 |
| TOTAL | $4,123 | $11,113 | $8,596 | $11,219 | $3,326 |
| Total Assets | $159,247 | $177,724 | $200,642 | $202,318 | $122,902 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 479 | 866 | 199 | 2,728 | 764 |
| Accrued Expenses | 6,622 | 7,028 | 9,659 | 9,752 | 10,977 |
| TOTAL | $12,711 | $12,560 | $14,039 | $18,366 | $11,741 |
| Non-Current Liabilities | |||||
| Long Term Debt | 86,152 | 82,333 | 78,685 | N/A | 23,259 |
| Other Non-Current Liabilities | 206 | 374 | 537 | 51,015 | 844 |
| TOTAL | $86,358 | $82,707 | $79,222 | $51,015 | $24,103 |
| Total Liabilities | $99,069 | $95,267 | $93,261 | $69,381 | $35,844 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,681 | 84,678 | 84,678 | 84,678 | 69,044 |
| Common Shares | 8 | 8 | 8 | 8 | 7 |
| Retained earnings | -846,224 | -821,719 | -794,625 | -766,856 | -740,313 |
| Other shareholders' equity | -574 | -441 | -219 | -13 | -1 |
| TOTAL | $60,178 | $82,457 | $107,381 | $132,937 | $87,058 |
| Total Liabilities And Equity | $159,247 | $177,724 | $200,642 | $202,318 | $122,902 |